MLTXMoonLake Immunotherapeutics Class A Ordinary Shares
15.76USD-5.85%Mkt Cap: 1.34B $P/E: —3d ago
MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Na…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.34B $
Enterprise Value915.15M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-227.32M $
Revenue/Share—
Last Price15.76 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees130
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.75
PEG—
EV/EBITDA-3.45
EV/Revenue—
P/S—
P/B3.10
EPS (TTM)-3.64
EPS (Forward)-3.34
52W Range
5.95017% of range62.75
52W High62.75 USD
52W Low5.950 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-74.66%
ROA-53.56%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-196.01M $
CapEx (TTM)35.00K $
FCF Margin—
FCF Yield-9.83%
Net Debt-435.50M $
Net Debt/EBITDA1.64
Balance Sheet
Debt/Equity0.25
Current Ratio12.56
Quick Ratio11.97
Book Value/Sh5.122 USD
Cash/Share6.310 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)28.54 USD
Upside (mean)+81.1%
Target Range6.000 USD – 50.00 USD
$6.000+81.1% to mean$50.00
# Analysts13
Ownership
Shares Out.85.11M
Float55.47M
Insiders8.18%
Institutions87.82%
Short Interest
Short Ratio5.3d
Short % Float9.27%
Short % Out.6.73%
Shares Short5.72M
Short (prev mo.)6.56M
Technical
SMA 5018.73 (-15.9%)
SMA 20016.69 (-5.6%)
Beta1.07
S&P 52W Chg18.16%
Avg Vol (30d)1.25M
Avg Vol (10d)1.81M
Technical Indicators
RSI (14)36.3
MACD-0.7584
MACD Signal-0.5866
MACD Hist.-0.1717
BB Upper20.02 USD
BB Middle17.75 USD
BB Lower15.47 USD
BB Width25.62%
ATR (14)0.9423 USD
Vol Ratio (20d)1.06x